Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (4): 386-388.DOI: 10.3969/j.issn.1673-8640.2015.04.021
Previous Articles Next Articles
Received:2014-05-08
Online:2015-04-30
Published:2015-05-16
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.04.021
| 抗菌药物种类 | 测定结果 | 标准要求 |
|---|---|---|
| 左氧氟沙星 | 1 | 0.5~2 |
| 莫西沙星 | 1 | 0.5~2 |
| 四环素 | ≥64 | - |
| 红霉素 | 4 | 1~8 |
| 泰利霉素 | 0.5 | 0.12~1 |
| 抗菌药物种类 | 测定结果 | 标准要求 |
|---|---|---|
| 左氧氟沙星 | 1 | 0.5~2 |
| 莫西沙星 | 1 | 0.5~2 |
| 四环素 | ≥64 | - |
| 红霉素 | 4 | 1~8 |
| 泰利霉素 | 0.5 | 0.12~1 |
| 抗菌药物 | MIC(μg/mL) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ≥64 | 32 | 16 | 8 | 4 | 2 | 1 | 0.5 | 0.25 | 0.125 | ≤0.063 | |
| 左氧氟沙星 | 9 | 7 | 11 | 15 | 22 | 28 | 38 | 43 | 23 | 14 | 9 |
| 莫西沙星 | 1 | 1 | 3 | 3 | 12 | 19 | 33 | 41 | 52 | 34 | 20 |
| 四环素 | 2 | 0 | 3 | 5 | 5 | 13 | 43 | 71 | 53 | 16 | 8 |
| 红霉素 | 6 | 11 | 16 | 12 | 17 | 24 | 37 | 42 | 29 | 19 | 6 |
| 泰利霉素 | 1 | 0 | 1 | 2 | 3 | 8 | 16 | 24 | 41 | 36 | 87 |
| 抗菌药物 | MIC(μg/mL) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ≥64 | 32 | 16 | 8 | 4 | 2 | 1 | 0.5 | 0.25 | 0.125 | ≤0.063 | |
| 左氧氟沙星 | 9 | 7 | 11 | 15 | 22 | 28 | 38 | 43 | 23 | 14 | 9 |
| 莫西沙星 | 1 | 1 | 3 | 3 | 12 | 19 | 33 | 41 | 52 | 34 | 20 |
| 四环素 | 2 | 0 | 3 | 5 | 5 | 13 | 43 | 71 | 53 | 16 | 8 |
| 红霉素 | 6 | 11 | 16 | 12 | 17 | 24 | 37 | 42 | 29 | 19 | 6 |
| 泰利霉素 | 1 | 0 | 1 | 2 | 3 | 8 | 16 | 24 | 41 | 36 | 87 |
| 抗菌药物 | 敏感 | 耐药 |
|---|---|---|
| 左氧氟沙星 | 155(70.78) | 64(29.22) |
| 莫西沙星 | 199(90.87)* | 20(9.13) |
| 四环素 | 191(87.21) | 28(12.79) |
| 红霉素 | 186(84.93) | 33(15.07) |
| 泰利霉素 | 215(98.17) | 4(1.83) |
| 抗菌药物 | 敏感 | 耐药 |
|---|---|---|
| 左氧氟沙星 | 155(70.78) | 64(29.22) |
| 莫西沙星 | 199(90.87)* | 20(9.13) |
| 四环素 | 191(87.21) | 28(12.79) |
| 红霉素 | 186(84.93) | 33(15.07) |
| 泰利霉素 | 215(98.17) | 4(1.83) |
| [1] | 王则宇,付光宇,苗兰芳,等.泌尿生殖道支原体和衣原体检测的现状和存在问题[J].中国皮肤性病学杂志,2003,17(5):343-344. |
| [2] | Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing for human mycoplasma;Approved guideline[S].M43-A,CLSI,2011. |
| [3] | 曹玉英,叶元康.支原体与支原体病[M].北京:人民卫生出版社,2000:292-313. |
| [4] | 张贤华,方萍,万雄萍,等.泌尿生殖道支原体感染现状及药敏结果分析[J].检验医学,2008,23(1):84-86. |
| [5] | WAITES KB, DUFFY LB, BÉBÉAR CM, et al. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of mycoplasma pneumoniae, mycoplasma hominis, and ureaplasma urealyticum[J]. J Clin Microbiol,2012, 50(11):3542-3547. |
| [6] | 汪涛. 氟喹诺酮类药物的临床应用[J].现代医药卫生,2011,27(15):2322-2324. |
| [7] | KECHAGIA N, BERSIMIS S, CHATZIPANAGIOTOU S.Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece[J].J Antimicrob Chemother,2008,62(1):122-125. |
| [8] | BAYRAKTAR MR, OZERO IH, GUCLUER N, et al.Prevalence and antibiotic susceptibility of mycoplasma hominis and ureaplasma urealyticum in pregnant women[J].Int J Infect Dis,2010,14(2):e90-e95. |
| [9] | 史莉,孙光成,宋涛.非淋病性尿道炎患者解脲脲支原体感染的耐药性调查[J].中华医院感染学杂志,2011,21(2):411-412. |
| [10] | 易光明,雷鸿斌,黄娥,等.荆州市性病高危人群解脲脲支原体感染及药物敏感性分析[J].中华医院感染学杂志,2011,21(3):608-609. |
| [1] | . [J]. Laboratory Medicine, 2023, 38(7): 692-695. |
| [2] | FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes [J]. Laboratory Medicine, 2023, 38(4): 357-361. |
| [3] | LIU Congcong, LI Jiaping, ZHOU Hongwei. Performance evaluation of 2 mass spectrometry systems in clinical microbial identification [J]. Laboratory Medicine, 2022, 37(11): 1084-1088. |
| [4] | . [J]. Laboratory Medicine, 2022, 37(10): 952-954. |
| [5] | LI Renqiang, LUO Junfeng, CHEN Yundi. Establishment and evaluation of α-thalassemia and β-thalassemia mutation determinations using hetero-tail dual-labeled fluorescent probe hydridization [J]. Laboratory Medicine, 2022, 37(10): 955-962. |
| [6] | BAO Hailin, HUA Hongyan, SUN Hengliang, LIU Hua, JI Shunnian, QIN Chenhao, DU Hong. Rapid identification of carbapenemase producing Enterobacteriaceae phenotypes by modified Carba Np test and mCIM/eCIM test [J]. Laboratory Medicine, 2022, 37(10): 963-968. |
| [7] | YANG Xi, SONG Wenqi, DONG Fang, MENG Qingying, ZHEN Jinghui, ZHOU Wei. Application of Gram staining and MALDI-TOF MS in the rapid identification of pathogen kinds in children's positive blood culture [J]. Laboratory Medicine, 2022, 37(10): 969-973. |
| [8] | WANG Lixin, SU Yunfu, WANG Yi. Research progress on the drug resistance mechanism of clinical pathogens to fosfomycin [J]. Laboratory Medicine, 2022, 37(10): 993-997. |
| [9] | YANG Xiaolan, HU Zengjun, WANG Shengqing, MA Shuxia, ZENG Yongjie, WANG Chenglei. Distribution of some common intestinal bacteria in elderly patients with acute cerebral infarction and its correlation with cognitive function [J]. Laboratory Medicine, 2022, 37(9): 839-843. |
| [10] | HAO Jiahui, YANG Zehua. Research progress of bacterial integron determination methods [J]. Laboratory Medicine, 2022, 37(9): 887-891. |
| [11] | LI Kun, ZHANG Guojun. Research progress of carbon quantum dots and graphene quantum dots in sensing field [J]. Laboratory Medicine, 2022, 37(8): 787-792. |
| [12] | CHEN Hanlu, WU Shenghai. Influence factors of blood culture negative results and progress of pathogen detection in bloodstream infection [J]. Laboratory Medicine, 2022, 37(7): 688-694. |
| [13] | DU Jinghui, HUANG Zikun, LIU Min, GONG Jingjing, WANG Dan, LIU Jibo, LIU Xu. Rapid determination of minimum inhibitory concentration and cut-off concentration of Mycobacterium tuberculosis by nitrate reductase assay using liquid medium [J]. Laboratory Medicine, 2022, 37(6): 568-576. |
| [14] | WEN Qinghui, LI Fengying, LI Yanchang, HUANG Jinyin, WANG Fengping. Drug susceptibility of multidrug-resistant ESBL-producing Escherichia coli to antimicrobial agents restored by different concentrations of EDTA [J]. Laboratory Medicine, 2022, 37(3): 205-208. |
| [15] | CHU Minjun, LI Xiaojuan, HUANG Hailin, LI Jue, MA Mingbiao, DU Tingyi, WANG Haiping. Influence of delayed entry on fastidious bacterium culture in 2 blood culture systems [J]. Laboratory Medicine, 2022, 37(3): 209-212. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
